Cytodyn Inc (CYDY)

[Bill_ENG]

" Who needs Covid ? "

A company with no revenue on the horizon for the next two years could probably use a pathway to make revenue and a pathway to use up expiring Leronlimab product.

LH is a phase 2, not even looking at starting much less completing a phase 3 till 2023, completion and BLA 2024 ?

Nash - Phase 3 maybe in 2022 completing in 2023. BLA ? 2023 or 2024 ?

HIV ? Let's see if they can submit a complete BLA at all, then see if it is accepted by the FDA then at end of 2022 maybe I'd lucky approved. That's combo therapy, not even mono therapy so mono therapy in 2024 ?

Covid was the only chance of saving this company from bankruptcy by cash injection and using up existing Leronlimab before it's worthless.

Jmo